» Authors » Hailong Si

Hailong Si

Explore the profile of Hailong Si including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Si H, Gao S, Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue . 2024 Sep; 36(8):887-891. PMID: 39238416
Artificial intelligence (AI) technology is advancing rapidly, constantly presenting its application value and broad prospects in the medical field. Especially in the early intervention of burn diseases, the new developments,...
2.
Si H, Chen K, Qin Q, Liu Y, Zhao B
Chin Med J (Engl) . 2023 Feb; 136(17):2044-2049. PMID: 36729845
Background: More than 75 million procedures with intravascular iodine-based contrast media (ICM) are performed worldwide every year, and some patients undergoing these procedures do not have normal thyroid function. The...
3.
Song Y, Yang N, Si H, Liu T, Wang H, Geng H, et al.
Biometals . 2022 Sep; 35(6):1325-1339. PMID: 36178540
Vascular calcification (VC) has been associated with a risk of cardiovascular diseases. Iron may play a critical role in progressive VC. Therefore, we investigated the effects of iron overload on...
4.
Zhao L, Yang N, Song Y, Si H, Qin Q, Guo Z
Ann Transl Med . 2022 Jan; 9(22):1658. PMID: 34988167
Background: Vascular calcification is related to many diseases. Iron has a certain relationship with endothelial cells and vascular calcification. The purpose of this study was to assess the effect of...
5.
Yang L, Si H, Ma M, Fang Y, Jiang Y, Wang J, et al.
Cancer Cell Int . 2021 Apr; 21(1):202. PMID: 33836753
Background: Microarray profiles of hepatocellular carcinoma (HCC) identified that long intergenic noncoding RNA 00221 (LINC00221) was upregulated. Herein, we aimed to identify the functional significance and underlying mechanisms of LINC00221...
6.
Si H, Wang H, Xiao H, Fang Y, Wu Z
Cancer Manag Res . 2021 Feb; 13:1099-1111. PMID: 33574707
Background: Celastrol is a potential anti-tumor agent in hepatocellular carcinoma (HCC). Identifying the molecular determinants of the anti-HCC effect of celastrol is still challenging. In this study, we undertook to...